Belimumab May Help Preserve eGFR Slope in Lupus Nephritis With MMF Induction

Summary: A recent study found great news for people with lupus nephritis, a condition that damages the kidneys. When doctors added a drug called belimumab to a standard treatment (MMF), patients' kidney function stayed stable for over two years. On the other hand, patients who took a placebo (a fake pill) saw their kidney health get worse. This means belimumab is a strong tool to help protect the kidneys in high-risk lupus patients, keeping them healthier and more active.

For more details, see rssapp-rheumatologyadvisor-com at rheumatologyadvisor.com/news/belimumab-may-help-preserve-egfr-slope-in-lupus-nephritis-with-mmf-induction/ (opens in new tab)